• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌中PTEN改变、TMPRSS2-ERG融合的频率及其关联

Frequency of PTEN alterations, TMPRSS2-ERG fusion and their association in prostate cancer.

作者信息

Fallahabadi Zahra Rafiei, Noori Daloii Mohammad Reza, Mahdian Reza, Behjati Farhkondeh, Shokrgozar Mohamad Ali, Abolhasani Maryam, Asgari Mojgan, Shahrokh Hossein

机构信息

Molecular Medicine Department, Pasteur Institute of Iran, Tehran, Iran; National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran; Medical Genetics Department, Tehran University of Medical Sciences, Tehran, Iran.

Medical Genetics Department, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Gene. 2016 Jan 10;575(2 Pt 3):755-60. doi: 10.1016/j.gene.2015.09.068. Epub 2015 Sep 28.

DOI:10.1016/j.gene.2015.09.068
PMID:26424596
Abstract

BACKGROUND

Phosphatase and tensin homolog (PTEN) gene aberration and trans membrane protease, serine 2 (TMPRSS2)-v-ets avian erythroblastosis virus E26 oncogene homolog (ERG) fusion are the most prevalent genomic events in prostate cancer. In this study we aimed to evaluate the frequency of PTEN alteration and TMPRSS2-ERG fusion and possible link between these two biomarkers in Iranian men.

METHODS

We assessed 42 fresh frozen tissue samples of prostate cancer (PCA) obtained by radical prostatectomy, interrogating the TMPRSS2-ERG fusion gene along with PTEN gene status using Real Time PCR and FISH methods.

RESULTS

Using Real Time PCR we identified the TMPRSS2-ERG fusion in 64% (27/42) of tumor samples, which was confirmed by FISH technique, giving 21 positive samples with deletion, suggesting the presence of TMPRSS2-ERG fusion gene. By contrast, PTEN deletion was detected in 52% (11/21) of PCA samples, which all showed low expression in Real Time. Concomitance of PTEN deletion or low expression and TMPRSS2-ERG fusion was present in PCA samples (P=0.005). All of the PTEN deletion samples showed TMPRSS2-ERG fusion, (11/11, 100%) while not all of the TMPRSS2-ERG fusion positive samples showed PTEN deletion. None of 29 cases of BPH and 8 cases of normal zone of tumor tissue showed TMPRSS2-ERG fusion.

CONCLUSIONS

These results indicate that PTEN loss occurs in cooperation with TMPRSS2-ERG fusion in PCA. While the majority of PCA samples harbor TMPRSS2-ERG fusion as well as PTEN gene deletion, normal tissues do not show these molecular aberrations.

摘要

背景

磷酸酶和张力蛋白同源物(PTEN)基因畸变以及跨膜蛋白酶丝氨酸2(TMPRSS2)-v-ets禽成红细胞增多症病毒E26癌基因同源物(ERG)融合是前列腺癌中最常见的基因组事件。在本研究中,我们旨在评估伊朗男性中PTEN改变和TMPRSS2-ERG融合的频率以及这两种生物标志物之间的可能联系。

方法

我们评估了42例通过根治性前列腺切除术获得的前列腺癌(PCA)新鲜冷冻组织样本,使用实时PCR和FISH方法检测TMPRSS2-ERG融合基因以及PTEN基因状态。

结果

使用实时PCR,我们在64%(27/42)的肿瘤样本中鉴定出TMPRSS2-ERG融合,FISH技术证实了这一结果,有21个阳性样本存在缺失,提示存在TMPRSS2-ERG融合基因。相比之下,在52%(11/21)的PCA样本中检测到PTEN缺失,所有这些样本在实时检测中均显示低表达。PCA样本中存在PTEN缺失或低表达与TMPRSS2-ERG融合的共存情况(P=0.005)。所有PTEN缺失样本均显示TMPRSS2-ERG融合(11/11,100%),而并非所有TMPRSS2-ERG融合阳性样本都显示PTEN缺失。29例良性前列腺增生(BPH)病例和8例肿瘤组织正常区域病例均未显示TMPRSS2-ERG融合。

结论

这些结果表明,在PCA中PTEN缺失与TMPRSS2-ERG融合共同发生。虽然大多数PCA样本同时存在TMPRSS2-ERG融合以及PTEN基因缺失,但正常组织未显示这些分子畸变。

相似文献

1
Frequency of PTEN alterations, TMPRSS2-ERG fusion and their association in prostate cancer.前列腺癌中PTEN改变、TMPRSS2-ERG融合的频率及其关联
Gene. 2016 Jan 10;575(2 Pt 3):755-60. doi: 10.1016/j.gene.2015.09.068. Epub 2015 Sep 28.
2
TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer.TMPRSS2-ERG 融合与低级别前列腺癌中年轻患者年龄密切相关。
Eur Urol. 2014 Dec;66(6):978-81. doi: 10.1016/j.eururo.2014.06.027. Epub 2014 Jul 9.
3
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome.前列腺癌中无TMPRSS2:ERG融合及PTEN缺失与良好预后相关。
Mod Pathol. 2008 Dec;21(12):1451-60. doi: 10.1038/modpathol.2008.96. Epub 2008 May 23.
4
PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.PTEN 缺失在多灶性前列腺腺癌中表现出异质性,并且与较高的 Gleason 分级相关。
Mod Pathol. 2013 Mar;26(3):435-47. doi: 10.1038/modpathol.2012.162. Epub 2012 Sep 28.
5
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.βIII-微管蛋白过表达是前列腺癌进展的一个独立预测因子,与 ERG 融合状态和 PTEN 缺失密切相关。
Am J Pathol. 2014 Mar;184(3):609-17. doi: 10.1016/j.ajpath.2013.11.007. Epub 2013 Dec 28.
6
The prognostic and predictive value of TMPRSS2-ERG gene fusion and ERG protein expression in prostate cancer biopsies.TMPRSS2-ERG基因融合及ERG蛋白表达在前列腺癌活检中的预后及预测价值
Dan Med J. 2016 Dec;63(12).
7
Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer.前列腺癌中PTEN缺失与ERG融合的异质性和时间顺序
Mod Pathol. 2014 Dec;27(12):1612-20. doi: 10.1038/modpathol.2014.70. Epub 2014 Apr 25.
8
TMPRSS2-ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer.与T1a期前列腺癌中PTEN缺失相比,TMPRSS2-ERG基因融合较为罕见。
Mol Carcinog. 2017 Mar;56(3):814-820. doi: 10.1002/mc.22535. Epub 2016 Aug 31.
9
Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset.在低级别前列腺癌中未发现同时存在的TMPRSS2-ERG和SLC45A3-ERG重排以及PTEN缺失,它们定义了一个侵袭性肿瘤亚组。
Prostate. 2016 Jun;76(9):854-65. doi: 10.1002/pros.23176. Epub 2016 Mar 9.
10
Prevalence and clinical application of fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review.融合在亚洲前列腺癌患者中的流行情况和临床应用:中国人的大样本研究和系统评价。
Asian J Androl. 2020 Mar-Apr;22(2):200-207. doi: 10.4103/aja.aja_45_19.

引用本文的文献

1
Exploring therapeutic applications of fusion, and tumour molecular subtypes in prostate cancer management.探索融合以及肿瘤分子亚型在前列腺癌治疗中的应用。
Front Oncol. 2025 Mar 17;15:1521204. doi: 10.3389/fonc.2025.1521204. eCollection 2025.
2
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.前列腺癌发生的细胞和分子机制:治疗意义
Medicines (Basel). 2019 Jul 30;6(3):82. doi: 10.3390/medicines6030082.
3
Translocations involving ETS family proteins in human cancer.人类癌症中涉及ETS家族蛋白的易位
Integr Cancer Sci Ther. 2018 Aug;5(4). doi: 10.15761/ICST.1000281. Epub 2018 Jul 20.
4
Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer.睡茄内酯A在PTEN缺陷型前列腺癌小鼠模型中抑制前列腺癌发生。
Neoplasia. 2017 Jun;19(6):451-459. doi: 10.1016/j.neo.2017.04.005. Epub 2017 May 7.
5
Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer.短尾相关蛋白作为雄激素受体活性的潜在调节因子以及前列腺癌治疗耐药性中的关键因素。
Oncotarget. 2016 May 17;7(20):28891-902. doi: 10.18632/oncotarget.8499.